相似文献
1
Exercise, cancer and cardiovascular disease: what should clinicians advise?
Cardiovasc Endocrinol Metab. 2020 Sep 3;10(2):62-71. doi: 10.1097/XCE.0000000000000228. eCollection 2021 Jun.
2
Exercise Therapy and Cardiovascular Toxicity in Cancer.
Circulation. 2018 Mar 13;137(11):1176-1191. doi: 10.1161/CIRCULATIONAHA.117.024671.
3
Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review.
Oncol Res Treat. 2023;46(4):131-139. doi: 10.1159/000529205. Epub 2023 Jan 18.
4
The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology.
Eur J Prev Cardiol. 2021 Jul 10;28(7):725-735. doi: 10.1177/2047487319874900.
5
Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors.
Curr Oncol. 2021 Oct 13;28(5):4139-4156. doi: 10.3390/curroncol28050351.
6
Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures.
Cardiooncology. 2016;2:1. doi: 10.1186/s40959-016-0011-5. Epub 2016 Feb 25.
7
Aerobic Exercise Training as a Potential Cardioprotective Strategy to Attenuate Doxorubicin-Induced Cardiotoxicity.
J Pharm Pharm Sci. 2016 Jul-Sep;19(3):399-410. doi: 10.18433/J3JS5R.
8
Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review.
Curr Oncol Rep. 2020 Jun 20;22(7):72. doi: 10.1007/s11912-020-00923-w.
9
Cardio-Oncology Rehabilitation-Present and Future Perspectives.
Life (Basel). 2022 Jul 7;12(7):1006. doi: 10.3390/life12071006.
10
Cardiac Complications in the Adult Bone Marrow Transplant Patient.
Curr Oncol Rep. 2019 Mar 2;21(3):28. doi: 10.1007/s11912-019-0774-6.
引用本文的文献
1
Evaluating the effects of exercise and phellodendron amurense on cardiac function in a prostate cancer mouse model.
J Appl Physiol (1985). 2025 Aug 1;139(2):465-472. doi: 10.1152/japplphysiol.00039.2025. Epub 2025 Jul 10.
2
Evaluation of Valid VO Criteria for Graded Exercise Testing in Cancer Survivors.
Int J Exerc Sci. 2025 May 1;18(5):443-455. doi: 10.70252/UKHO9411. eCollection 2025.
3
Association of lifestyle modification with the development of cardiovascular disease in gastric cancer patients who underwent gastrectomy: A nationwide population-based study.
Cancer Med. 2024 Jul;13(14):e70038. doi: 10.1002/cam4.70038.
4
Navigating cancer therapy induced cardiotoxicity: From pathophysiology to treatment innovations.
Adv Drug Deliv Rev. 2024 Aug;211:115361. doi: 10.1016/j.addr.2024.115361. Epub 2024 Jun 18.
5
Factors Influencing the Decision of Individuals with Breast Cancer to Join an Exercise Oncology Trial.
J Cancer Educ. 2024 Jun;39(3):244-252. doi: 10.1007/s13187-024-02403-2. Epub 2024 Feb 28.
6
Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: State-of-the-Art Review.
JACC CardioOncol. 2023 Oct 17;5(5):553-569. doi: 10.1016/j.jaccao.2023.08.008. eCollection 2023 Oct.
7
The Mediterranean Lifestyle to Contrast Low-Grade Inflammation Behavior in Cancer.
Nutrients. 2023 Mar 29;15(7):1667. doi: 10.3390/nu15071667.
8
Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues.
Front Cardiovasc Med. 2022 Aug 9;9:925816. doi: 10.3389/fcvm.2022.925816. eCollection 2022.
9
Understanding Myocardial Metabolism in the Context of Cardio-Oncology.
Heart Fail Clin. 2022 Jul;18(3):415-424. doi: 10.1016/j.hfc.2022.02.004.
本文引用的文献
1
Pre-Diagnosis Exercise and Cardiovascular Events in Primary Breast Cancer: Women's Health Initiative.
JACC CardioOncol. 2019 Sep 24;1(1):41-50. doi: 10.1016/j.jaccao.2019.08.014. eCollection 2019 Sep.
2
Exercise Interventions in Cardio-Oncology Populations: A Scoping Review of the Literature.
J Cardiovasc Nurs. 2021;36(4):385-404. doi: 10.1097/JCN.0000000000000664.
3
Increased skeletal intermuscular fat is associated with reduced exercise capacity in cancer survivors: a cross-sectional study.
Cardiooncology. 2019 May 3;5:3. doi: 10.1186/s40959-019-0038-5. eCollection 2019.
4
Effects of Exercise Therapy Dosing Schedule on Impaired Cardiorespiratory Fitness in Patients With Primary Breast Cancer: A Randomized Controlled Trial.
Circulation. 2020 Feb 18;141(7):560-570. doi: 10.1161/CIRCULATIONAHA.119.043483. Epub 2020 Feb 17.
5
Preventive Cardio-Oncology: The Time Has Come.
Front Cardiovasc Med. 2020 Jan 10;6:187. doi: 10.3389/fcvm.2019.00187. eCollection 2019.
6
Exercise Intolerance in Anthracycline-Treated Breast Cancer Survivors: The Role of Skeletal Muscle Bioenergetics, Oxygenation, and Composition.
Oncologist. 2020 May;25(5):e852-e860. doi: 10.1634/theoncologist.2019-0777. Epub 2020 Jan 17.
7
Effects of physical exercise on outcomes of cardiac (dys)function in women with breast cancer undergoing anthracycline or trastuzumab treatment: study protocol for a systematic review.
Syst Rev. 2019 Oct 24;8(1):239. doi: 10.1186/s13643-019-1154-x.
8
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association.
Circulation. 2019 May 21;139(21):e997-e1012. doi: 10.1161/CIR.0000000000000679.
9
Two-year follow-up of the OptiTrain randomised controlled exercise trial.
Breast Cancer Res Treat. 2019 Jun;175(3):637-648. doi: 10.1007/s10549-019-05204-0. Epub 2019 Mar 26.
10
Exercise Therapy and Cardiovascular Toxicity in Cancer.
Circulation. 2018 Mar 13;137(11):1176-1191. doi: 10.1161/CIRCULATIONAHA.117.024671.
Zotero 插件